These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18261866)

  • 21. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field.
    Cerqueira-Coutinho C; Dos Santos EP; Mansur CR
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):195-212. PubMed ID: 27651102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs.
    Lee MK; Kim S; Ahn CH; Lee J
    Int J Pharm; 2010 Jan; 384(1-2):173-80. PubMed ID: 19788919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
    Zimmermann A; Millqvist-Fureby A; Elema MR; Hansen T; Müllertz A; Hovgaard L
    Eur J Pharm Biopharm; 2009 Jan; 71(1):109-16. PubMed ID: 18619536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization.
    Newton JM; Pinto MR; Podczeck F
    Eur J Pharm Sci; 2007 Mar; 30(3-4):333-42. PubMed ID: 17223021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugs.
    Chan Y; Bulmus V; Zareie MH; Byrne FL; Barner L; Kavallaris M
    J Control Release; 2006 Oct; 115(2):197-207. PubMed ID: 16996635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced drug dissolution using evaporative precipitation into aqueous solution.
    Sarkari M; Brown J; Chen X; Swinnea S; Williams RO; Johnston KP
    Int J Pharm; 2002 Aug; 243(1-2):17-31. PubMed ID: 12176292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers.
    Roberts AD; Zhang H
    Int J Pharm; 2013 Apr; 447(1-2):241-50. PubMed ID: 23499755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of surface-adsorbed excipients of various types on drug particles prepared by antisolvent precipitation using HPLC with evaporative light scattering detection.
    Zimmermann A; Elema MR; Hansen T; Müllertz A; Hovgaard L
    J Pharm Biomed Anal; 2007 Aug; 44(4):874-80. PubMed ID: 17531425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods.
    Peltonen L; Hirvonen J
    J Pharm Pharmacol; 2010 Nov; 62(11):1569-79. PubMed ID: 21039542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals.
    Brewster ME; Verreck G; Chun I; Rosenblatt J; Mensch J; Van Dijck A; Noppe M; Ariën A; Bruining M; Peeters J
    Pharmazie; 2004 May; 59(5):387-91. PubMed ID: 15212307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations.
    Xing Y; Lu P; Xue Z; Liang C; Zhang B; Kebebe D; Liu H; Liu Z
    Mini Rev Med Chem; 2020; 20(13):1258-1271. PubMed ID: 32386491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
    Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
    J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of the Amorphous Structure of Spray-Dried Drug Nanoparticles.
    Amstad E; Spaepen F; Weitz DA
    J Phys Chem B; 2016 Sep; 120(34):9161-5. PubMed ID: 27441485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
    Ha JU; Xanthos M
    Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.